#LiverTwitter
TOMORROW! NRG will be hosting a webinar for the NRG-GI011 "LAP100" study in #PancreaticCancer and the NRG-GI012 "HELIO-RT" study in hepatocellular carcinoma with macrovascular invasion #LiverTwitter - Register here: https://acr-org.zoom.us/webinar/register/WN_zogcWQ1yRbGl9D6JM6rxGg
November 1, 2026 at 9:00 PM
ONE WEEK AWAY! NRG will be hosting a webinar for the NRG-GI011 "LAP100" study in #PancreaticCancer and the NRG-GI012 "HELIO-RT" study in hepatocellular carcinoma with macrovascular invasion #LiverTwitter - Register here: https://acr-org.zoom.us/webinar/register/WN_zogcWQ1yRbGl9D6JM6rxGg
October 26, 2026 at 12:00 PM
NRG will be hosting a webinar for 2 of our active studies in the NRG GI CRC space. Learn more about NRG-GI011 "LAP100" in #PancreaticCancer & NRG-GI012 "HELIO-RT" in hepatocellular carcinoma with macrovascular invasion #LiverTwitter - Register here: https://ow.ly/8l2150ZSO5k
October 13, 2026 at 12:00 PM
NRG will be hosting a webinar for 2 of our active studies in the NRG GI CRC space. Learn more about NRG-GI011 "LAP100" in #PancreaticCancer & NRG-GI012 "HELIO-RT" in hepatocellular carcinoma with macrovascular invasion #LiverTwitter - Register here: https://ow.ly/xCc850ZSO1r
October 1, 2026 at 3:00 PM
Spotlight 💫: Could platelets serve as a therapeutic target in alcohol-associated hepatitis? doi.org/10.1172/jci....
Matthew J. McConnell & colleagues report platelets upregulate inflammatory mediators in alcohol-associated hepatitis that can contribute to liver inflammation.
#livertwitter #AlcHep
September 12, 2026 at 1:00 PM
🇪🇹 Two weeks to COLDA 2026.
The 9th Conference on Liver Disease in Africa opens 17 September at the Hilton Addis Ababa.
📣 3 days of capacity building
🦠 Viral hepatitis
🎗️ Liver cancer
🫀 Transplantation
🍽️ Metabolic liver disease

See you in Addis 👋

#COLDA2026 #LiverTwitter
September 7, 2026 at 2:23 AM
Fantastic to see the updated BSG/BASL decompensated cirrhosis admission bundle in print at FG
- practical guidance to improve care in the first 24 hours as well as implementation strategy - congrats Stuart McPherson for driving this! #livertwitter

fg.bmj.com/content/earl...
Decompensated cirrhosis: an update of the BSG/BASL admission care bundle
Acute decompensated cirrhosis (DC) and acute-on-chronic liver failure are common reasons for hospital admission that have a high in-hospital mortality rate (10%–20%). Patients require a detailed asses...
fg.bmj.com
April 16, 2025 at 6:54 PM
Great to see our paper examining real-world applicability of telemonitoring interventions published in FG! Fantastic working with Dee Kumar, Kohi Gananandan, @jennieclough.bsky.social and Guy Robinson on this! #livertwitter #gitwitter

fg.bmj.com/content/early/2025/04/08/flgastro-2024-102997
April 8, 2025 at 5:56 PM
Thanks to all that completed the first round of the UK CLIF JLA research priority setting process for decompensated cirrhosis - if you live with or care/work with patients with cirrhosis - please take some time to go through these research questions #livertwitter

www.surveymonkey.com/r/SMMF6XJ
Survey: Priorities for Liver Cirrhosis Research
Take this survey powered by surveymonkey.com. Create your own surveys for free.
www.surveymonkey.com
March 31, 2025 at 8:02 PM
Exhibitor booths are not usually meeting highlights but this is an exception. Kudos to @boehringerglobal.bsky.social
on this artistic rendition on the theme of liver health and disease @easlnews.bsky.social #EASLCongress
#livertwitter
May 7, 2025 at 12:51 PM
Out of sequence allocation is sometimes unavoidable. This report is very disturbing especially for NEO hospitals.
#livertwitter
Organ Transplant System ‘in Chaos’ as Waiting Lists Are Ignored
The sickest patients are supposed to get priority for lifesaving transplants. But more and more, they are being skipped over.
www.nytimes.com
March 1, 2025 at 7:52 PM
It’s interesting how we in the US are even politicizing this issue. The source of course is now suspect in the eyes of some and the former surgeon general is just that…
#medtwitter #livertwitter
February 17, 2025 at 5:32 PM
Reading the #baveno7 consensus paper again tonight. Undoubtedly the biggest overhaul of clinical #hepatology practice in the past 40 years. I don’t agree with all of the recommendations but a tremendous amount of education needs to go into disseminating them #LiverTwitter
December 3, 2024 at 2:03 AM
I was asked today to address a hepatology perspective on “alcohol use disorder awareness and social justice” I found zero references on the topic. anyone? @rabataller #livertwitter
December 3, 2024 at 2:03 AM
Ever since I started routinely checking PETH as part of my initial ALT⬆️ or imaging c/w steatosis, I would estimate that easily 20% I thought had #NAFLD were reclassified as alcohol related liver disease #LiverTwitter
December 3, 2024 at 1:53 AM
I can now safely say that #ELF is my jam when it comes to assessing fibrosis in #NAFLD. #livertwitter
December 3, 2024 at 1:53 AM
@EASLnews Less than 2 days to the start of #ILC2022. Highlights for me will be all things Baveno and checkpoint inhibitor immune mediated hepatitis. Staples of modern hepatology practice. #LiverTwitter
December 3, 2024 at 1:53 AM
#Fazirsiran for Liver Disease Associated with #A1ATD This may be the first step towards filling a great unmet need #livertwitter https://www.nejm.org/doi/full/10.1056/NEJMoa2205416
December 3, 2024 at 12:57 AM
I have to say this is shaping up to be a lot closer than I thought it would be! #HCC biomarker optimists, REVEAL YOURSELVES! #LiverTwitter
December 3, 2024 at 12:57 AM
I have to say this was closer than anticipated. Glad people are bullish on a functional cure for #HBV #LiverTwitter
@EASLnews @AASLDtweets what is likely to be the next biggest advance in #hepatology? #LiverTwitter
December 3, 2024 at 12:57 AM
@EASLnews @AASLDtweets what is likely to be the next biggest advance in #hepatology? #LiverTwitter
December 3, 2024 at 12:52 AM
Not to poo poo impact factors but…would you rather have your work published in @NEJM or @TheLancet ?
I mean…either way…tremendous but… #LiverTwitter
December 3, 2024 at 12:52 AM
After rounding for less than a week on the #hepatology service @UHhospitals I would say that ICI mediated hepatitis is in the top 5 reasons for consultation. The times they have changed #livertwitter
December 3, 2024 at 12:52 AM
Light up some patchouli and slowly repeat these affirmations after me

❌I do not need to correct the INR and platelets to do a paracentesis
❌I do not need an INR<1.5 to place an ICP monitor in ALF. It will never happen (but should I place an ICP monitor…ever?)
#livertwitter
December 3, 2024 at 12:52 AM
Alcohol is the top contributor to the burden of liver disease in the #COVID era. It behooves us to become facile in treating persons with alcohol use disorders. #baclofen is not a silver bullet but the evidence is there #livertwitter
https://pubmed.ncbi.nlm.nih.gov/31833590/
Titrated baclofen for high-risk alcohol consumption: a ra...
Baclofen was more effective than placebo in reducing alco...
pubmed.ncbi.nlm.nih.gov
December 3, 2024 at 12:52 AM